Clinical Trial: A Phase 1 Study of NM6603 in Advanced Solid Tumors
Study Status: Completed
Recruit Status: RECRUITING
Condition: Cancers
Study Type: INTERVENTIONAL
Official Title: A Phase I Study to Determine the Maximum Tolerated Dose and Evaluate Safety, Tolerability, and Pharmacokinetics of NM6603 in Patients With Advanced Solid Tumors
Brief Summary:
This study is to assess the MTD and RP2D of NM6603 in adult patients with advanced solid tumors.
Read more